---
layout: post
title: "International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; “Effectiveness of Anthelmintics: Specific Recommendations for Equines (Revision 1)”; Draft Guidance for Industry; Availability"
date: 2026-02-05 19:00:14 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-17347
original_published: 2022-08-12 00:00:00 +0000
significance: 8.00
---

# International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; “Effectiveness of Anthelmintics: Specific Recommendations for Equines (Revision 1)”; Draft Guidance for Industry; Availability

**Published:** February 05, 2026 19:00 UTC
**Source:** Federal Register
**Original Published:** August 12, 2022 00:00 UTC
**Document Number:** 2022-17347

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry (GFI) #109 (VICH GL15(R1)) entitled "Effectiveness of Anthelmintics: Specific Recommendations for Equines (Revision 1)." This draft guidance has been developed for veterinary use by the International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH). This revision clarifies the definition of adequate infection in individual animals, updates considerations for field studies, and makes additional clarifying changes.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/08/12/2022-17347/international-cooperation-on-harmonisation-of-technical-requirements-for-registration-of-veterinary)
- API: https://www.federalregister.gov/api/v1/documents/2022-17347

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
